CA2047043A1 - Proteine de classe ii de la membrane externe de neisseria meningitidis ayant des proprietes de stimulation du systeme immunitaire - Google Patents

Proteine de classe ii de la membrane externe de neisseria meningitidis ayant des proprietes de stimulation du systeme immunitaire

Info

Publication number
CA2047043A1
CA2047043A1 CA002047043A CA2047043A CA2047043A1 CA 2047043 A1 CA2047043 A1 CA 2047043A1 CA 002047043 A CA002047043 A CA 002047043A CA 2047043 A CA2047043 A CA 2047043A CA 2047043 A1 CA2047043 A1 CA 2047043A1
Authority
CA
Canada
Prior art keywords
miep
protein
prp
outer membrane
ompc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002047043A
Other languages
English (en)
Inventor
Allen I. Oliff
Margaret A. Liu
Arthur Friedman
Joseph Y. Tai
John J. Donnelly
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2047043A1 publication Critical patent/CA2047043A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CA002047043A 1990-07-19 1991-07-15 Proteine de classe ii de la membrane externe de neisseria meningitidis ayant des proprietes de stimulation du systeme immunitaire Abandoned CA2047043A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US55520490A 1990-07-19 1990-07-19
US555,204 1990-07-19
US63945791A 1991-01-10 1991-01-10
US639,457 1996-04-29

Publications (1)

Publication Number Publication Date
CA2047043A1 true CA2047043A1 (fr) 1992-01-20

Family

ID=27070823

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002047043A Abandoned CA2047043A1 (fr) 1990-07-19 1991-07-15 Proteine de classe ii de la membrane externe de neisseria meningitidis ayant des proprietes de stimulation du systeme immunitaire

Country Status (9)

Country Link
JP (1) JPH0656690A (fr)
KR (1) KR920002631A (fr)
AU (1) AU8114091A (fr)
CA (1) CA2047043A1 (fr)
FI (1) FI913473A7 (fr)
IL (1) IL98837A0 (fr)
MX (1) MX9100272A (fr)
NO (1) NO912822L (fr)
PT (1) PT98381A (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2323845T3 (es) * 1999-04-30 2009-07-27 Novartis Vaccines And Diagnostics, Inc. Secuencias genomicas de neisseria y procedimientos de uso.
GB0011108D0 (en) * 2000-05-08 2000-06-28 Microscience Ltd Virulence gene and protein and their use

Also Published As

Publication number Publication date
FI913473A0 (fi) 1991-07-18
MX9100272A (es) 1992-02-28
NO912822L (no) 1992-01-20
KR920002631A (ko) 1992-02-28
PT98381A (pt) 1992-05-29
NO912822D0 (no) 1991-07-18
FI913473L (fi) 1992-01-20
FI913473A7 (fi) 1992-01-20
JPH0656690A (ja) 1994-03-01
AU8114091A (en) 1992-01-23
IL98837A0 (en) 1992-07-15

Similar Documents

Publication Publication Date Title
US4695624A (en) Covalently-modified polyanionic bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins with bigeneric spacers, and methods of preparing such polysaccharides and conjugates and of confirming covalency
US5371197A (en) Protein-dimeric polysaccharide conjugate vaccine
EP0186576B1 (fr) Polysaccharides bactériens neutres modifiés de manière covalente, conjugés stables covalents entre ces polysaccharides et des protéines immunogéniques et méthodes de préparation de ces polysaccharides et conjugués
US4882317A (en) Covalently-modified bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins with bigeneric spacers and methods of preparing such polysaccharides and conjugataes and of confirming covalency
US4459286A (en) Coupled H. influenzae type B vaccine
EP0467714A1 (fr) Classe II de la membrane extérieure de Neisseria meningitidis et raccins la contenant
JPH0794472B2 (ja) 肺炎連鎖球菌多糖結合体ワクチン
PL226184B1 (pl) Poliwalentna sprzezona szczepionka meningokokowa polisacharyd- bialko
DK163176B (da) Ugiftig konjugatvaccine mod infektioner af pseudomonas aeruginosa- og escherichia coli- bakterier, fremgangsmaade til fremstilling heraf og anvendelse af vaccinen
US10716847B2 (en) Haemophilus influenzae fusion protein and construction method and use thereof
CA2047043A1 (fr) Proteine de classe ii de la membrane externe de neisseria meningitidis ayant des proprietes de stimulation du systeme immunitaire
CA2047030A1 (fr) Proteine de classe ii de la membrane externe de neisseria meningitidis ayant des proprietes de vecteur et de stimulateur immunologique
CN101829337B (zh) 针对脑膜炎奈瑟氏球菌的免疫组合物
CN104096224B (zh) 一种增强流行性嗜血杆菌b型多糖蛋白结合物免疫原性的方法
JPH0616569A (ja) 免疫学的担体特性および免疫促進特性を有するナイセリア・メニンギチジスの外膜のクラスｉｉ蛋白、およびそれを含むワクチン
BG60630B2 (bg) Ковалентно модифицирани полианионни бактериални полизахариди,техни стабилни ковалентни конюгати с имуногенни протеини свързани с хибридни молекули,
HK1136220B (zh) 蛋白质基质疫苗及这种疫苗的制备和给药方法

Legal Events

Date Code Title Description
FZDE Discontinued